inhaled beta-agonists MIGHT increase the risk of heart attacks in COPD patients
June 2002
There's new concern that inhaled beta-agonists MIGHT increase the risk of heart attacks in COPD patients.
Many COPD patients get albuterol or another inhaled beta-agonist to improve breathing.
But new evidence suggests a higher risk of unstable angina and heart attacks in patients using inhaled beta-agonists.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote